De Barbieri A, Crovari P, Cuneo-Crovari P, Giacometti G
Dev Biol Stand. 1977;39:73-6.
A/Port Chalmers 1/73 and A/Victoria 3/75 live vaccines were well tolerated after oral administration and showed good immunogenic properties in subjects devoid of immune-defence or having low antibody titer. A/Victoria 3/75 vaccine was prepared before the epidemiological appearance of the corresponding virus which demonstrates that the preparation of a vaccine with new strains can be made in a comparatively short time. Our experiments and controls allow us to establish that the oral administration of influenza virus, grown on chicken kidney embryo, elicits the appearance of HI antibodies in a high number of susceptible subjects. A 60% seroconversion rate obtained after administration of two doses represents a favourable result, the more so as the vaccine can be considered absolutely safe in very young subjects.
A/查尔姆斯港1/73和A/维多利亚3/75活疫苗经口服后耐受性良好,在缺乏免疫防御或抗体滴度较低的受试者中显示出良好的免疫原性。A/维多利亚3/75疫苗是在相应病毒出现流行病学特征之前制备的,这表明用新毒株制备疫苗可以在相对较短的时间内完成。我们的实验和对照使我们能够确定,口服在鸡胚肾细胞上培养的流感病毒,能使大量易感受试者产生血凝抑制(HI)抗体。接种两剂后获得的60%的血清转化率是一个良好的结果,特别是因为该疫苗在非常年幼的受试者中可被认为是绝对安全的。